-logo.jpg "AmerisourceBergen logo")
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company's Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and co-pay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; specialty transportation and logistics services for the biopharmaceutical industry; and animal health care products. It markets its products and services through independent sales forces and marketing organizations. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:ABC
CUSIP03073E10
Phone610-727-7000
Debt
Debt-to-Equity Ratio1.38
Current Ratio0.94
Quick Ratio0.48
Price-To-Earnings
Trailing P/E Ratio15.90
Forward P/E Ratio14.47
P/E Growth1.42
Sales & Book Value
Annual Sales$153.14 billion
Price / Sales0.13
Cash Flow$7.9915 per share
Price / Cash11.70
Book Value$9.47 per share
Price / Book9.87
Profitability
EPS (Most Recent Fiscal Year)$5.88
Net Income$364.48 million
Net Margins0.57%
Return on Equity51.04%
Return on Assets3.83%
Miscellaneous
Employees20,000
Outstanding Shares219,800,000
AmerisourceBergen (NYSE:ABC) Frequently Asked Questions
What is AmerisourceBergen's stock symbol?
AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."
How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?
AmerisourceBergen declared a quarterly dividend on Thursday, May 10th. Shareholders of record on Monday, May 21st will be paid a dividend of $0.38 per share on Monday, June 4th. This represents a $1.52 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date is Friday, May 18th. View AmerisourceBergen's Dividend History.
How were AmerisourceBergen's earnings last quarter?
AmerisourceBergen Corp. (NYSE:ABC) issued its quarterly earnings results on Wednesday, May, 2nd. The company reported $1.96 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.83 by $0.13. The company had revenue of $41.03 billion for the quarter, compared to the consensus estimate of $40.56 billion. AmerisourceBergen had a net margin of 0.57% and a return on equity of 51.04%. The business's revenue was up 10.5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.77 earnings per share. View AmerisourceBergen's Earnings History.
When is AmerisourceBergen's next earnings date?
What guidance has AmerisourceBergen issued on next quarter's earnings?
AmerisourceBergen updated its FY18 earnings guidance on Wednesday, May, 2nd. The company provided EPS guidance of $6.45-6.65 for the period, compared to the Thomson Reuters consensus estimate of $6.55. The company issued revenue guidance of +8-11% to ~$165.4-170.0 billion, compared to the consensus revenue estimate of $167.81 billion.
What price target have analysts set for ABC?
16 equities research analysts have issued 12-month target prices for AmerisourceBergen's stock. Their forecasts range from $87.00 to $115.00. On average, they anticipate AmerisourceBergen's stock price to reach $103.0714 in the next year. View Analyst Ratings for AmerisourceBergen.
Who are some of AmerisourceBergen's key competitors?
Who are AmerisourceBergen's key executives?
AmerisourceBergen's management team includes the folowing people:
- Mr. Steven H. Collis, Chairman, Pres & CEO (Age 57)
- Mr. Tim G. Guttman, Exec. VP & CFO (Age 59)
- Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 62)
- Dr. Robert P. Mauch, Exec. VP and Group Pres of Pharmaceutical Distribution & Strategic Global Sourcing (Age 51)
- Mr. James D. Frary, Exec. Officer (Age 46)
Has AmerisourceBergen been receiving favorable news coverage?
News headlines about ABC stock have been trending somewhat positive on Sunday, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. AmerisourceBergen earned a daily sentiment score of 0.08 on Accern's scale. They also assigned news stories about the company an impact score of 47.97 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
Who are AmerisourceBergen's major shareholders?
AmerisourceBergen's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.56%), Franklin Resources Inc. (1.76%), Wells Fargo & Company MN (1.30%), Burgundy Asset Management Ltd. (1.24%), FIL Ltd (1.22%) and Northern Trust Corp (1.09%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Lon R Greenberg, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Institutional Ownership Trends for AmerisourceBergen.
Which institutional investors are selling AmerisourceBergen stock?
ABC stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, FIL Ltd, Allen Investment Management LLC, Artisan Partners Limited Partnership, OMERS ADMINISTRATION Corp, Royal Bank of Canada, Franklin Resources Inc. and Thompson Siegel & Walmsley LLC. Company insiders that have sold AmerisourceBergen company stock in the last year include Dale Danilewitz, Gina Clark, John G Chou, Kathy H Gaddes, Lazarus Krikorian, Peyton R Howell, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View Insider Buying and Selling for AmerisourceBergen.
Which institutional investors are buying AmerisourceBergen stock?
ABC stock was bought by a variety of institutional investors in the last quarter, including Ceredex Value Advisors LLC, Coho Partners Ltd., Wedge Capital Management L L P NC, Mackay Shields LLC, Rock Springs Capital Management LP, DekaBank Deutsche Girozentrale, Caisse DE Depot ET Placement DU Quebec and State of Tennessee Treasury Department. View Insider Buying and Selling for AmerisourceBergen.
How do I buy shares of AmerisourceBergen?
Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is AmerisourceBergen's stock price today?
One share of ABC stock can currently be purchased for approximately $93.50.
How big of a company is AmerisourceBergen?
AmerisourceBergen has a market capitalization of $20.49 billion and generates $153.14 billion in revenue each year. The company earns $364.48 million in net income (profit) each year or $5.88 on an earnings per share basis. AmerisourceBergen employs 20,000 workers across the globe.
How can I contact AmerisourceBergen?
AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]
MarketBeat Community Rating for AmerisourceBergen (ABC)
MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote "Outperform" if you believe ABC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.
